MiNK Therapeutics INKT
NASDAQ INKT
$12.26 +0.15 (+1.24%)
At close: Sep 29, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Non-Current Debt (2024)

Updated

MiNK Therapeutics (INKT) posted Non-Current Debt of $4.92 million for Q4 2024, up 6.8% from the prior quarter.

Analysis

MiNK Therapeutics (INKT) Non-Current Debt (2024) Analysis & Trends

Since Q1 2024, MiNK Therapeutics has reported Non-Current Debt for 4 quarters.

  • According to Business Quant data, Non-Current Debt for the three prior quarters was $4.61 million (Q3 2024), $4.41 million (Q2 2024) and $4.21 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 MiNK Therapeutics 61.82 Mn 61.82 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 4.92 Mn
Sep 30, 2024 4.61 Mn
Jun 30, 2024 4.41 Mn
Mar 31, 2024 4.21 Mn
API Access

MiNK Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=INKT&period=max&api_key=YOUR_API_KEY